The above chart presents the market trend analysis for meiji seika pharma co ltd. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 11 transactions, with a transaction quantity of 69629 and a transaction weight of 0.
YearTransactionsQuantityWeight
20252064943892.060
202611696290
Bill of lading data
<
1/15
>
Trade date
2026/04/16
B/L No.
108154927310
Suppliers
meiji seika pharma co ltd.
Buyers
công ty cổ phần dược phẩm thiên thảo
Product description
Fosmicin tablets 500, hộp 2 vỉ x 10 viên nén (Fosfomycin Calcium Hydrate 500mg), VN-15983-12, Batch No: VFOMT 43, Nsx/Hsd: 01/09/2025-31/08/2028, (Đ.trị viêm phổi)
Expand
Trade date
2026/01/23
B/L No.
4586327
Suppliers
meiji seika pharma co ltd.
Buyers
medreich ltd.
POLs
——
PODs
bangalore
Supply area
Japan
Purchas area
India
Weight
——
Amount
384.2
Hs code
39129090
Product tags
raw material,r pharm,carmellose,al product,cellulose,iu,cali
Product description
RAW MATERIAL FOR PHARMACEUTICAL PRODUCTS CARMELLOSE CALICUM CELLULOSE PH 101 RAW MATERIAL FOR PHARMACEUTICAL PRODUCTS CARMELLOSE CALCIU
Expand
Trade date
2026/01/18
B/L No.
0807504
Suppliers
meiji seika pharma co ltd.
Buyers
medreich ltd.
POLs
——
PODs
bangalore
Supply area
Japan
Purchas area
India
Weight
——
Amount
295.8
Hs code
29349990
Product tags
raw material,r pharm,microcrystalline,liga,megnesium stearate,al product
Product description
RAW MATERIAL FOR PHARMACEUTICAL PRODUCTS MEGNESIUM STEARATE LIGAMED MF 3 V MB RAW MATERIAL FOR PHARMACEUTICAL PRODUCTS MICROCRYSTALLINE
Expand
Trade date
2026/01/18
B/L No.
1087642
Suppliers
meiji seika pharma co ltd.
Buyers
medreich ltd.
POLs
——
PODs
bangalore
Supply area
Japan
Purchas area
India
Weight
——
Amount
5403.6
Hs code
39129090
Product tags
raw material,r pharm,microcrystalline,al product,cellulose,rat,stea,magnesium
Product description
RAW MATERIAL FOR PHARMACEUTICAL PRODUCTS MICROCRYSTALLINECELLULOSE CELLULOSE PH 101 RAW MATERIAL FOR PHARMACEUTICAL PRODUCTS MAGNESIUM STEARAT
Expand
Trade date
2026/01/18
B/L No.
8722443
Suppliers
meiji seika pharma co ltd.
Buyers
medreich ltd.
POLs
——
PODs
bangalore
Supply area
Japan
Purchas area
India
Weight
——
Amount
1930.5
Hs code
11081200
Product tags
raw material,r pharm,corn starch,al product,pravastatin,mosapride
Product description
RAW MATERIAL FOR PHARMACEUTICAL PRODUCTS CORN STARCH W CORN STARCH JP FOR PRAVASTATIN MOSAPRIDE RAW MATERIAL FOR PHARMACEUTICAL PRODUCTS
Expand
Trade date
2026/01/18
B/L No.
5068488
Suppliers
meiji seika pharma co ltd.
Buyers
medreich ltd.
POLs
——
PODs
bangalore
Supply area
Japan
Purchas area
India
Weight
——
Amount
1311.25
Hs code
29349990
Product tags
al product,raw material,phosphate,r pharm,disodium hydrogen
Product description
RAW MATERIAL FOR PHARMACEUTICAL PRODUCTS DISODIUM HYDROGENPHOSPHATERAW MATERIAL FOR PHARMACEUTICAL PRODUCTS DISODIUM HYDROGEN
Expand
Trade date
2026/01/18
B/L No.
8174767
Suppliers
meiji seika pharma co ltd.
Buyers
medreich ltd.
POLs
——
PODs
bangalore
Supply area
Japan
Purchas area
India
Weight
——
Amount
768.4
Hs code
39129090
Product tags
raw material,r pharm,al product,car,iu,calcium,lp,e c g
Product description
RAW MATERIAL FOR PHARMACEUTICAL PRODUCTS CARMELLPSE CALCIUM E C G 505 RAW MATERIAL FOR PHARMACEUTICAL PRODUCTS CARMELLPSE CALCIU
Expand
Trade date
2026/01/18
B/L No.
5830076
Suppliers
meiji seika pharma co ltd.
Buyers
medreich ltd.
POLs
——
PODs
bangalore
Supply area
Japan
Purchas area
India
Weight
——
Amount
131.7
Hs code
29349990
Product tags
raw material,r pharm,megnesium stearate,al product,iu,rat,stea
Product description
RAW MATERIAL FOR PHARMACEUTICAL PRODUCTS MEGNESIUM STEARATERAW MATERIAL FOR PHARMACEUTICAL PRODUCTS MEGNESIUM STEARAT
Expand
Trade date
2026/01/18
B/L No.
4351531
Suppliers
meiji seika pharma co ltd.
Buyers
medreich ltd.
POLs
——
PODs
bangalore
Supply area
Japan
Purchas area
India
Weight
——
Amount
1702.5
Hs code
39129090
Product tags
al product,raw material,hydroxypropyl cellulose,r pharm,pc
Product description
RAW MATERIAL FOR PHARMACEUTICAL PRODUCTS HYDROXYPROPYL CELLULOSE HPC L RAW MATERIAL FOR PHARMACEUTICAL PRODUCTS
Expand
Trade date
2025/12/20
B/L No.
8575066
Suppliers
meiji seika pharma co ltd.
Buyers
medreich ltd.
POLs
——
PODs
bangalore
Supply area
Japan
Purchas area
India
Weight
——
Amount
1674.8
Hs code
29349990
Product tags
rosuvastatin
Product description
ROSUVASTATIN JP W S ROSUVASTATIN JP W S
Expand
Trade date
2025/12/16
B/L No.
107803490760
Suppliers
meiji seika pharma co ltd.
Buyers
công ty tnhh nipro pharma việt nam
POLs
——
PODs
——
Supply area
Other
Purchas area
Vietnam
Weight
——
Amount
18136
Hs code
83099099
Product tags
bottle cap
Product description
2100012301#&Nắp nhôm cho lọ đựng thuốc VCMND, bọc bên ngoài nắp cao su, không tiếp xúc trực tiếp với thuốc ,hàng mới 100%
Expand
Trade date
2025/12/08
B/L No.
4364745
Suppliers
meiji seika pharma co ltd.
Buyers
medreich ltd.
meiji seika pharma co ltd. is japan Buyer&Supplier,
and primarily engages in the import and export business of products such as raw material,r pharm,al product.
According to the 52wmb.com global trade database, as of 2026-04-16, the company has completed 3604 international trades,
with its main trading regions covering india,indonesia,vietnam etc.
The core products include HS29349990,HS29054300,HS29339990 etc,
often transported via tokyo,port narita apt tokyo, port yokohama etc,
and its main trading partners are medreich ltd.,meiji indonesian pharmaceutical industries,thien thao pharmaceutical joint sto.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on meiji seika pharma co ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.